Back to search

Vaccicure Limited

08988870

active
ltd
england wales
Companies House
Accounts overdue
Health Score
60 / 100

Some Concerns

10/30
Filing
10/30
Financial
40/40
Risk
  • Accounts filing overdue (-15)
  • No accounts filed in last 18 months (-5)
  • Negative net worth (-10)

Details

101 New Cavendish Street, 1st Floor South, London, W1W 6XH
Incorporated 09/04/2014

Compliance

Last accounts

31/12/2023

small

Next accounts due

06/10/2025

Overdue

Confirmation statement

Last: 03/07/2026

Due 17/07/2027

On track

Industry

74909
Other professional, scientific and technical activities

Officers

Jr. John Henry Wingen

director · Since 09/04/2014

VICE PRESIDENT FINANCE

AMERICAN · UNITED STATES · Age 68

Lynda Youngpeter Sutton

director · Since 09/04/2014

COMPANY PRESIDENT

AMERICAN · UNITED STATES · Age 70

Mr Laurence John Cohen

director · Since 07/07/2015

LAWYER

BRITISH · ENGLAND · Age 74

Also on 10 other boards

Jr. Wingen

director · Since 09/04/2014

American · United States · Age 68

Lynda Youngpeter Sutton

director · Since 09/04/2014

American · United States · Age 70

Laurence John Cohen

director · Since 07/07/2015

British · England · Age 74

Former

Ian Rudolf Ferrier

director · Resigned 01/11/2016

Arthur Sydney Edward Fowle

director · Resigned 27/12/2019

Lee Roy Mccracken

director · Resigned 01/04/2021

Jr. Cato

director · Resigned 25/07/2022

Warren Charles Stern

director · Resigned 28/06/2024

Persons with Significant Control

Cancer Advances Inc

75–100% shares
75–100% votes
Appoint directors
Significant control

4364, S Alston Ave, Durham, 27713

Notified 06/04/2016

Change History

statusactive
2026-07-27

Active

typeltd
2026-07-27

Private Limited Company

address line1101 New Cavendish Street
2026-07-27

101 NEW CAVENDISH STREET

post townLondon
2026-07-27

LONDON

officer appointedCOHEN, Laurence John
2026-07-27
officer appointedSUTTON, Lynda Youngpeter
2026-07-27
officer appointedWINGEN, JR., John Henry
2026-07-27

CompanyRankvs 50038+ SIC 74909 peers
33

Financial strength0th percentile among SIC peers · 0/25
Employees96th percentile among SIC peers · 14/15
LiquidityCurrent ratio 0.14× · 2/20
Longevity12 years trading (max 15) · 12/15
Filing complianceOne filing overdue · 5/15
Show leaderboard
How is this score calculated?
Financial strength0/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity12/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance5/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2023

Net Worth

-£1.2M

Balance sheet strength

Cash

£973

Cash in the bank

Net Current Assets

-£6k

Working capital

Current Assets

£973

Current Liabilities

£7k

8avg. employees

Balance Sheet

Assets less current liabilities-£6k
Prepared with Caseware UK (AP4) 2023.0.135

EstimatesDerived

YearCurrent Ratio
20230.14

Derived from filed accounts. Not audited figures.